SCH28080, a K+-Competitive Inhibitor of the Gastric H,K-ATPase, Binds Near the M5−6 Luminal Loop, Preventing K+ Access to the Ion Binding Domain
- 26 September 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 41 (42) , 12755-12762
- https://doi.org/10.1021/bi025921w
Abstract
Inhibition of the gastric H,K-ATPase by the imidazo[1,2-α]pyridine, SCH28080, is strictly competitive with respect to K+ or its surrogate, NH4+. The inhibitory kinetics [Vmax, Km,app(NH4+), Ki(SCH28080), and competitive, mixed, or noncompetitive] of mutants can define the inhibitor binding domain and the route to the ion binding region within M4−6. While mutations Y799F, Y802F, I803L, S806N, V807I (M5), L811V (M5−6), Y928H (M8), and Q905N (M7−8) had no effect on inhibitor kinetics, mutations P798C, Y802L, P810A, P810G, C813A or -S, I814V or -F, F818C, T823V (M5, M5−6, and M6), E914Q, F917Y, G918E, T929L, and F932L (M7−8 and M8) reduced the affinity for SCH28080 up to 10-fold without affecting the nature of the kinetics. In contrast, the L809F substitution in the loop between M5 and M6 resulted in an ∼100-fold decrease in inhibitor affinity, and substitutions L809V, I816L, Y925F, and M937V (M5−6, M6, and M8) reduced the inhibitor affinity by 10-fold, all resulting in noncompetitive kinetics. The mutants L811F, Y922I, and I940A also reduced the inhibitor affinity up to 10-fold but resulted in mixed inhibition. The mutations I819L, Q923V, and Y925A also gave mixed inhibition but without a change in inhibitor affinity. These data, and the 9-fold loss of SCH28080 affinity in the C813T mutant, suggest that the binding domain for SCH28080 contains the surface between L809 in the M5−6 loop and C813 at the luminal end of M6, approximately two helical turns down from the ion binding region, where it blocks the normal ion access pathway. On the basis of a model of the Ca-ATPase in the E2 conformation (PDB entry 1kju), the mutants that change the nature of the kinetics are arranged on one side of M8 and on the adjacent side of the M5−6 loop and M6 itself. This suggests that mutations in this region modify the enzyme structure so that K+ can access the ion binding domain even with SCH28080 bound.Keywords
This publication has 11 references indexed in Scilit:
- A Hybrid between Na+,K+-ATPase and H+,K+-ATPase Is Sensitive to Palytoxin, Ouabain, and SCH 28080Journal of Biological Chemistry, 2001
- Comparison of Covalent with Reversible Inhibitor Binding Sites of the Gastric H,K-ATPase by Site-directed MutagenesisPublished by Elsevier ,2000
- Identification of the Site of Inhibition by Omeprazole of a α-β Fusion Protein of the H,K-ATPase Using Site-directed MutagenesisJournal of Biological Chemistry, 1998
- Sites of Reaction of the Gastric H,K-ATPase with Extracytoplasmic Thiol ReagentsJournal of Biological Chemistry, 1997
- Role of Negatively Charged Residues in the Fifth and Sixth Transmembrane Domains of the Catalytic Subunit of Gastric H+,K+-ATPaseJournal of Biological Chemistry, 1996
- Ouabain Interactions with the H5-H6 Hairpin of the Na,K-ATPase Reveal a Possible Inhibition Mechanism via the Cation Binding DomainPublished by Elsevier ,1996
- Identification of an extracytoplasmic region of H+,K(+)-ATPase labeled by a K(+)-competitive photoaffinity inhibitor.Journal of Biological Chemistry, 1991
- SCH28080 prevents omeprazole inhibition of the gastric H+/K+-ATPaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1988
- Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.Journal of Biological Chemistry, 1987
- A nonelectrogenic H+ pump in plasma membranes of hog stomach.Journal of Biological Chemistry, 1976